Literature DB >> 27393119

Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs.

Mitchell K P Lai1, Wee Siong Chew1, Federico Torta2, Angad Rao1, Greg L Harris3, Jerold Chun4, Deron R Herr5,6.   

Abstract

Sphingolipids (SPs) comprise a highly diverse class of lipids that serve biological roles both as structural components of cell membranes and as mediators of cell signaling. Pharmacologic and genetic manipulation of SPs and their signaling systems have underscored their importance in most biological processes, including central nervous system development and function. Likewise, perturbations of SP accumulation or signaling have been associated with a number of disease states, such as neural tube defects, neuroinflammation, stroke, and dementia. SPs can be endogenously synthesized de novo, and their metabolism is a well-regulated process, so their value as nutraceuticals has not been scrutinized. However, there is evidence that sphingolipid-rich diets can affect lipid homeostasis, and several mycotoxins are SP analogs that are known to cause profound derangement of SP metabolism or signaling. Furthermore, plants and invertebrates have SP species that are not present in mammals. Several of these have been shown to induce biological responses in mammalian cells. These findings suggest that dietary intake of SPs or SP analogs may have significant effects on human health or disease outcome. This manuscript provides an overview of SP metabolism and signaling, their perturbations in neurological diseases, as well as potential impacts of modulating this system in the brain.

Entities:  

Keywords:  Ceramide; Fingolimod; Nutraceutical; Review; Sphingolipid; Sphingosine 1-phosphate receptor

Mesh:

Substances:

Year:  2016        PMID: 27393119     DOI: 10.1007/s12017-016-8424-8

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  210 in total

Review 1.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

Review 2.  Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.

Authors:  Gregory T Kunkel; Michael Maceyka; Sheldon Milstien; Sarah Spiegel
Journal:  Nat Rev Drug Discov       Date:  2013-08-19       Impact factor: 84.694

3.  Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720.

Authors:  S Enosawa; S Suzuki; T Kakefuda; X K Li; H Amemiya
Journal:  Immunopharmacology       Date:  1996-09

4.  The principles of Tetragonia tetragonoides having anti-ulcerogenic activity. II. Isolation and structure of cerebrosides.

Authors:  E Okuyama; M Yamazaki
Journal:  Chem Pharm Bull (Tokyo)       Date:  1983-07       Impact factor: 1.645

5.  Ubiquitin pathway proteins influence the mechanism of action of the novel immunosuppressive drug FTY720 in Saccharomyces cerevisiae.

Authors:  Carole A Welsch; Shinji Hagiwara; Jean Francois Goetschy; N Rao Movva
Journal:  J Biol Chem       Date:  2003-04-22       Impact factor: 5.157

6.  Abnormality of water barrier function in psoriasis. Role of ceramide fractions.

Authors:  S Motta; M Monti; S Sesana; L Mellesi; R Ghidoni; R Caputo
Journal:  Arch Dermatol       Date:  1994-04

7.  Ceramide 1-phosphate enhances calcium entry through voltage-operated calcium channels by a protein kinase C-dependent mechanism in GH4C1 rat pituitary cells.

Authors:  Kid Törnquist; Tomas Blom; Ramin Shariatmadari; Michael Pasternack
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

8.  S1P1 deletion in oligodendroglial lineage cells: Effect on differentiation and myelination.

Authors:  Danuta E Dukala; Betty Soliven
Journal:  Glia       Date:  2015-12-11       Impact factor: 7.452

9.  Sphingosine 1-phosphate induces the production of glial cell line-derived neurotrophic factor and cellular proliferation in astrocytes.

Authors:  Kazuo Yamagata; Motoki Tagami; Yasuyoshi Torii; Fumio Takenaga; Shigehisa Tsumagari; Shingo Itoh; Yukio Yamori; Yasuo Nara
Journal:  Glia       Date:  2003-01-15       Impact factor: 7.452

10.  Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2.

Authors:  Sathya Narayanan Patmanathan; Steven P Johnson; Sook Ling Lai; Suthashini Panja Bernam; Victor Lopes; Wenbin Wei; Maha Hafez Ibrahim; Federico Torta; Pradeep Narayanaswamy; Markus R Wenk; Deron R Herr; Paul G Murray; Lee Fah Yap; Ian C Paterson
Journal:  Sci Rep       Date:  2016-05-10       Impact factor: 4.379

View more
  6 in total

1.  Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence.

Authors:  Wee Siong Chew; Federico Torta; Shanshan Ji; Hyungwon Choi; Husna Begum; Xueling Sim; Chin Meng Khoo; Eric Yin Hao Khoo; Wei-Yi Ong; Rob M Van Dam; Markus R Wenk; E Shyong Tai; Deron R Herr
Journal:  JCI Insight       Date:  2019-06-04

2.  Subunit composition of the mammalian serine-palmitoyltransferase defines the spectrum of straight and methyl-branched long-chain bases.

Authors:  Museer A Lone; Andreas J Hülsmeier; Essa M Saied; Gergely Karsai; Christoph Arenz; Arnold von Eckardstein; Thorsten Hornemann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-23       Impact factor: 11.205

Review 3.  'Crystal' Clear? Lysophospholipid Receptor Structure Insights and Controversies.

Authors:  Victoria A Blaho; Jerold Chun
Journal:  Trends Pharmacol Sci       Date:  2018-11       Impact factor: 14.819

Review 4.  Ceramide and Sphingosine Regulation of Myelinogenesis: Targeting Serine Palmitoyltransferase Using microRNA in Multiple Sclerosis.

Authors:  Somsankar Dasgupta; Swapan K Ray
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

5.  Diverse Biological Functions of Sphingolipids in the CNS: Ceramide and Sphingosine Regulate Myelination in Developing Brain but Stimulate Demyelination during Pathogenesis of Multiple Sclerosis.

Authors:  Somsankar Dasgupta; Swapan K Ray
Journal:  J Neurol Psychol       Date:  2017-12-23

6.  Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment.

Authors:  Xin Ying Chua; Yuek Ling Chai; Wee Siong Chew; Joyce R Chong; Hui Li Ang; Ping Xiang; Kaddy Camara; Amy R Howell; Federico Torta; Markus R Wenk; Saima Hilal; Narayanaswamy Venketasubramanian; Christopher P Chen; Deron R Herr; Mitchell K P Lai
Journal:  Alzheimers Res Ther       Date:  2020-09-30       Impact factor: 6.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.